Search and analyze individual stocks with comprehensive metrics

Checkpoint Trend

CHECKPOINTPharmaceuticals & Biotechnology

Fundamental Score

...

Checkpoint Trend Share Price & Market Analysis

Current Market Price (CMP)
57.18
No change data available
Market Cap
24.70 (Cr)
Industry
Pharmaceuticals & Biotechnology

Profitability Metrics

Poor

Return on Equity

9.17%
Good

Return on Capital Employed

16.51%
Poor

Operating Profit Margin (5Y)

0.76%
Poor

Dividend Yield

0.00%

Valuation Metrics

Poor

Price to Earnings

274.46x

Market Capitalization

24.70 (Cr)

Industry P/E

33.97x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

350.00%
Excellent

YoY Quarterly Sales Growth

11610.00%
Poor

Sales Growth (5Y)

-12.77%
Excellent

EPS Growth (5Y)

37.97%
Excellent

Profit Growth (5Y)

37.97%

Financial Health

Excellent

Debt to Equity

0.00x

Interest Coverage

N/A
Average

Free Cash Flow (5Y)

0.22 (Cr)

Ownership Structure

Poor

Promoter Holding

0.00%
Good

FII Holding

10.86%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
0.00%
Promoter Holding
24.70 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of CHECKPOINT across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Excellent ROCE Performance (16.51%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Robust Profit Growth (350.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (11610.00%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Excellent EPS Growth (37.97% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.

Strong Profit Growth Track Record (37.97% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

9 factors identified

Below-Average Return on Equity (9.17%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Margin Pressure Concerns (0.76%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.

Premium Valuation Risk (P/E: 274.46x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

Limited Growth History (-12.77% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.

Low Promoter Commitment (0.00%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Very High P/E Ratio

Observation: Significant overvaluation risk present.

Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

📊 Educational Market Overview

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.

Loading Peer Comparison

Finding companies in the Pharmaceuticals sector...

Financial Statements

Comprehensive financial data for Checkpoint Trend

About CHECKPOINT

Company Details

Symbol:CHECKPOINT
Industry:Pharmaceuticals & Biotechnology
Sector:Pharmaceuticals

Market Information

Market Cap:24.70 (Cr)
P/E Ratio:274.46
Beta:N/A

Performance

52W High:N/A
52W Low:N/A
Dividend Yield:0.00%

CHECKPOINT Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)9.17%
Return on Capital Employed16.51%
Operating Profit Margin (5Y)0.76%
Debt to Equity Ratio0.00
Interest Coverage RatioN/A

Growth & Valuation

Sales Growth (5Y)-12.77%
Profit Growth (5Y)37.97%
EPS Growth (5Y)37.97%
YoY Quarterly Profit Growth350.00%
YoY Quarterly Sales Growth11610.00%

Frequently Asked Questions

What is the current price of CHECKPOINT?

CHECKPOINT is currently trading at ₹57.18 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of CHECKPOINT shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.

What is the P/E ratio of CHECKPOINT and what does it mean?

CHECKPOINT has a P/E ratio of 274.46x compared to the industry average of 33.97x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹274 for every ₹1 of annual earnings. This is higher than the industry average, suggesting either growth premium or potential overvaluation.

How is CHECKPOINT performing according to Bull Run's analysis?

CHECKPOINT has a Bull Run fundamental score of 47.2/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 9.17%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.

What sector and industry does CHECKPOINT belong to?

CHECKPOINT operates in the Pharmaceuticals & Biotechnology industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Checkpoint Trend. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.

What is Return on Equity (ROE) and why is it important for CHECKPOINT?

CHECKPOINT has an ROE of 9.17%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Checkpoint Trend generates profits from shareholders' equity. An ROE of 9% means the company generates ₹9 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.

How is CHECKPOINT's debt-to-equity ratio and what does it indicate?

CHECKPOINT has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. This means the company has ₹0 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.

What is CHECKPOINT's dividend yield and is it a good dividend stock?

CHECKPOINT offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.

How has CHECKPOINT grown over the past 5 years?

CHECKPOINT has achieved 5-year growth rates of: Sales Growth -12.77%, Profit Growth 37.97%, and EPS Growth 37.97%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.

What is the promoter holding in CHECKPOINT and why does it matter?

Promoters hold 0.00% of CHECKPOINT shares, with 0.00% of promoter shares pledged. This promoter holding level suggests balanced ownership between management and public shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.

How does CHECKPOINT compare with its industry peers?

CHECKPOINT trades at P/E 274.46x vs industry average 33.97x, with ROE of 9.17% and ROCE of 16.51%. The stock trades at a premium to industry average, which may be justified by superior fundamentals. Peer comparison helps identify whether CHECKPOINT is outperforming its competitive set in profitability, growth, and valuation metrics.

What is CHECKPOINT's market capitalization and what category does it fall into?

CHECKPOINT has a market capitalization of ₹25 crores, making it a Small-cap stock. Small-cap stocks offer high growth potential but with higher volatility and risk. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.

What are the key financial ratios to consider for CHECKPOINT?

Key ratios for CHECKPOINT: ROE 9.17% (Needs improvement), ROCE 16.51%, P/E 274.46x, Debt-to-Equity 0.00, Interest Coverage N/Ax. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.

How volatile is CHECKPOINT stock and what is its beta?

CHECKPOINT has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.

What is the 52-week high and low for CHECKPOINT?

CHECKPOINT has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹57.18, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.

What are the key risks associated with investing in CHECKPOINT?

Key risks for CHECKPOINT include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.00), and operational challenges. The stock has a Fundamental Score of 47.2/100, indicating higher risk requiring thorough due diligence. Sector-specific risks in Pharmaceuticals & Biotechnology include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.

What is CHECKPOINT's operating profit margin and how has it trended?

CHECKPOINT has a 5-year average Operating Profit Margin (OPM) of 0.76%, which suggests room for improvement in operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.

How is CHECKPOINT's quarterly performance in terms of sales and profit growth?

CHECKPOINT's recent quarterly performance shows YoY Sales Growth of 11610.00% and YoY Profit Growth of 350.00%. This strong double-digit growth indicates excellent business momentum and management execution. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.

What is the FII and DII holding pattern in CHECKPOINT?

CHECKPOINT has FII holding of 10.86% and DII holding of 0.00%, totaling 10.86% institutional ownership. This institutional participation level shows the confidence of professional money managers. Significant FII holding suggests global investor confidence and potential for index inclusion. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.